Table 1—

Eligibility criteria and characteristics of participants with IGT in major diabetes prevention trials

StudyEligibility criteria
Actual participants
AgeBMIFPG (mg/dl)Mean ageMean BMIMean FPG (mg/dl)
Malmo (29)47–49NSNS47–49>25NG
Da Qing (30)NSNSNS44>25NG
Finnish (31; J. Tuomilehto, personal communication)40–65≥25NS5531110
DPP (33,34)≥25≥2495–1255134106
TRIPOD (35)NSNSNS353094
STOP-NIDDM (36,37)40–7025–40101–13955>31101–139
  • NG, not given; NS, not specified or relevant to eligibility.